Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate
Pintiaux, A.; Gaspard, U.; Nisolle, M.
Revue Medicale de Liege 67(3): 152-156
2012
ISSN/ISBN: 0370-629X PMID: 22611833 Document Number: 623026
A new combined oral contraceptive called Zoely has just been marketed in Belgium. It contains nomegestrol acetate, a progestin known for its high contraceptive reliability based on its antigonadotropic power and long half-life. This progestin is associated with estradiol and Zoely is devoid of ethinyl estradiol, which is the usual component of the majority of combined oral contraceptives and is primarily responsible for thrombotic side effects of the pill. The compositon and type of regimen of this new oral contraceptive contribute to its efficacy and excellent clinical tolerance.
Document emailed within 1 workday
Related Documents
Mansour, D.; Verhoeven, C.; Sommer, W.; Weisberg, E.; Taneepanichskul, S.; Melis, G.B.; Sundström-Poromaa, I.; Korver, T. 2011: Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 430-443Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Ågren, U.M.; Anttila, M.; Mäenpää-Liukko, K.; Rantala, M.-L.; Rautiainen, H.; Sommer, W.F.; Mommers, E. 2011: Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 458-467
Grandi, G.; Napolitano, A.; Xholli, A.; Tirelli, A.; Di Carlo, C.; Cagnacci, A. 2015: Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(10): 774-778
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Burke, A. 2013: Nomegestrol acetate-17b-estradiol for oral contraception Patient Preference and Adherence 7: 607-619
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Molina, R.C.; Sandoval, J.Z.; Montero, A.V.; Oyarzún, P.G.; Molina, T.ís.G.; González, E.A. 2009: Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents Journal of Pediatric and Adolescent Gynecology 22(1): 25-31
2012: Estradiol + nomegestrol. Oral contraceptive claimed to be more natural, but presenting no obvious advantages Prescrire international 21(133): 292
Ruan, X.; Schneck, H.; Schultz, S.; Fehm, T.; Cahill, M.A.; Seeger, H.; Chen, R.; Yu, Q.; Mueck, A.O.; Neubauer, H. 2012: Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 28(11): 863-866
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Cromer, B.A.; Smith, R.D.; Blair, J.M.; Dwyer, J.; Brown, R.T. 1994: A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception Pediatrics 94(5): 687-694
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Briggs, P.; Serrani, M.; Vogtländer, K.; Parke, S. 2016: Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study International Journal of Women's Health 8: 477-487
Rekers, H. 1988: Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel Acta Obstetricia et Gynecologica Scandinavica 67(2): 171-174
De Kam, P.-J.; van Kuijk, J.; Lillin, O.; Post, T.; Thomsen, T. 2014: The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial Clinical Drug Investigation 34(6): 413-420
Niemann, J.; Schenk, L.; Stadler, G.; Richter, M. 2022: What happens when you stop using the combined contraceptive pill? a qualitative study protocol on consequences and supply needs for women who discontinued the combined contraceptive pill in Germany Bmj Open 12(6): E057089
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Jensen, J.T.; Archer, D.F.; Westhoff, C.L.; Nelson, A.L.; Graham, S.; Bernick, B. 2023: Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users Journal of Women's Health 32(7): 808-815
Boerrigter, P.J.; Ellman, H.; Dolker, M. 1999: International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg Clinical Therapeutics 21(1): 118-127